++
For further information, see CMDT Part 15-05: Sideroblastic Anemia
++
Presence of ringed sideroblasts in the bone marrow
Elevated serum iron levels and transferrin saturation
Heterogeneous group of disorders in which reduced hemoglobin synthesis occurs because of
Iron accumulates, particularly in mitochondria
Modern classification divides sideroblastic anemia into two categories
Dyserythropoiesis (ie, hypohepcidinemia)
Transfusion-dependent, eg
Most often it is a subtype of myelodysplastic neoplasms
Other causes include
Chronic alcohol use disorder
Lead poisoning
Copper deficiency (hypocupremia)
Medications
Isoniazid
Chloramphenicol
Chronic infection or inflammation
Inherited forms are usually X-linked but rare recessive forms have been documented
++
Symptoms of anemia; no other specific clinical features
In hypocupremia (copper deficiency), myelopathy or demyelinating peripheral neuropathy in some patients
++
Anemia usually moderate, hematocrit 20–30%
Mean corpuscular volume (MCV)
Peripheral blood smear characteristically shows
In cases of lead poisoning
Bone marrow iron stain shows
Serum iron level and transferrin saturation are high
In hypocupremia
Normocytic anemia in two-thirds of cases; macrocytic in remainder
Zinc level is often elevated due to
Neutropenia or thrombocytopenia may be present
Bone marrow biopsy
++
Occasionally, red blood cell transfusion is required for severe anemia
Recombinant erythropoietin therapy is not usually effective
Oral pyridoxine (50–200 mg/day) occasionally useful
Removal of offending toxins and drugs is needed in the secondary acquired forms
Luspatercept
FDA approved for myelodysplastic neoplasms with ringed sideroblasts
It is a TGF-β ligand trap
Promotes erythroid maturation
Reduces need for transfusion
Hypocupremia
Administer copper sulfate (2.5 mg orally twice daily)
Associated with high hematologic response rate but low neurologic response rate
Exogenous or endogenous zinc exposure needs to be eliminated
Refer to hematologist if diagnostic or transfusion support is needed.